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1. Introduction 
1,25(OH)2D3 is considered to be the active metab- 
olite of vitamin D, particularly in the intestine. This 
compound isproduced in vivo from vitamin D by 
C-25 hydroxylation i the liver, followed by C-1 
hydroxylation i the kidney. When 1,25(OH)2D3 
interacts with intestinal cells, a specific CaBP is 
formed. 
The characteristic functional groups of 1,25(OH)2D3 
are the Is, 313 and 25-hydroxy groups. Of these, only 
the 3/3-hydroxyl is present in the parent vitamin 
molecule. Therefore, the 2-step transformation f
the active form raises the question of the significance 
of this hydroxy group for the intermediary metab- 
olism and the subsequent biological activity of the 
vitamin. Previous tudies have shown however, that 
3-deoxy analogues of 1,25(OH)2D3 are only slightly 
less potent biologically than the natural metabolite 
[1-3]. 
This paper eports the chemical synthesis of 
3-deoxy-D3 and 3-deoxy-25(OH)D3 and their biolog- 
ical activity in chicks. The latter was evaluated by 
monitoring rowth, plasma calcium, bone ash, duo- 
denal CaBP and the renal 25(OH)D3-1-hydroxyiase. 
Abbreviations: D3, vitamin D3; 25(OH)D3, 25-hydroxy- 
vitamin D3; I(OH)Da, 1-hydroxyvitamin D3;1,25(OH)~D3, 
1,25-dihydroxyvitamin D3; CaBP, calcium-binding protein; 
TLC, thin-layer chromatography 
2. Experimental 
2.1. Measurements of biological activity 
Day-old White Leghorn males kept in a window- 
less room were fed for 28 days a semi-purified vitamin 
D-deficient diet containing 1.2% calcium and 0.7% 
phosphorus [4]. At the age of 21 days, the chicks 
were divided into 5 groups. Birds of each group were 
injected subcutaneously either with daily doses of 
0.25/~g D3, 0.25 or 100 ~g 3-deoxy-D3, or 0.25 or 
100 ~zg 3-deoxy-25(OH)D3. The sterols were dissolved 
in propylene glycol. 
At the age of 28 days, heparinized blood samples 
were obtained from 6 birds of each group before they 
were killed by dislocation of the neck. Plasma cal- 
cium concentration was determined by an EGTA 
titration using an automatic titrator (Precision 
Systems, USA). The duodenal mucosa was homog- 
enized [5] and assayed for CaBP using a radio- 
immunoassay with a sensitivity of 30 pg [6]. 
Bones were cleaned of adhering tissues, dried and 
ashed [7]. 
2.2. Synthesis of  3-deoxy-25{OHJD3 and 3-deoxy-D3 
(scheme 1) 
2.2.1.3-Tosyl-25(OH)D3 (2b) 
150 mg Of 25(OH)D3 (lb) were dissolved in 4 ml 
dry pyridine. The solution was treated with 115 mg 
tosyl chloride and left at room temperature (25°C) 
overnight. The reaction mixture was then extracted 
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Scheme 1 
Synthetic steps for the preparation of 3-deoxy-D~ 
and 3-deoxy-25(OH)D3 
by 1H NMR spectroscopy signals at 8 0.55, 1.13, 
4.66, 4.92, 5.92 and 9.02 ppm, m/e (M ÷) 384.3375 
(calc. 384.3392). 
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with diethyl ether, washed with cold 5% aq. HC1 and 
with water, and dried over MgSO4. The diethyl ether 
was evaporated and the residue was chromatographed 
on a preparative silica-gel TLC plate with diethyl 
ether. The resulting compound (2b) (100 rag) 
(ultraviolet Xma x 264 nm, 232 nm; e, 17 500, 14 000 
1. mo1-1 . cm -1) showed by IH NMR spectroscopy 
signals at 8 0.55, 1.13, 4.66, 4.76, 4.99, 5.87, 6.02, 
7.26 and 7.71 ppm, m/e (M ÷) 554. 
2.2.2.3-Deoxy-D3 ( a) 
Drtosylate (2a) [8] 100 mg were dissolved in 6 ml 
dry tetrahydrofuran d chilled to 0°C. The solution 
was treated with 0.2 ml 2 M lithium triisobutylboro- 
hydride solution and was left for 30 rain at 0°C and 
6 h at room temperature (25°C). Excess hydride was 
decomposed with water. The organoborane was 
oxidized with 5 ml 3 N NaOH and 5 ml 30% H202. 
The mixture was then extracted with pentane, washed 
with water and dried over MgSO4. The dry residue was 
chromatographed on a preparative silica-gel TCL plate 
with hexane. The resulting compound, 3-deoxy-D3 
(3 a) (20 mg) (Xmax, 264 nm;e, 17 5001. mol- 1 cm- 1), 
showed by 1H NMR spectroscopy signals at 6 0.55, 
4.66, 4.92, 5.92 and 6.02 ppm, m/e (M ÷) 366.3464 
(calc. 366.3453). 
2,2.3.3-Deoxy-25(OH)Da (3b) 
3-Tosyl-25(OH)Ds (2b), 100 rag, were treated as 
above but the resulting reaction mixture was 
chromatographed on a preparative silica-gel TLC 
plate with hexane/diethyl ether (2:1, v/v). The 
resulting compound 3-deoxy-25(OH)Da (3b) (15 mg) 
(~'max 264 nm; e, 17 5001. mol -I cm -1) showed 
2.3. Renal 25( OH)Da- l-hydroxylase 
Three vitamin D-deficient chicks were killed by 
decapitation, their kidneys were removed, washed 
with cold saline, pooled and homogenised. The 
homogenate was assayed for 1-hydroxylase activity 
by 10 rain incubation with [26, 27-aH]25(OH)Da 
or [26, 27-3H]3-deoxy-25(OH)D3 assubstrates [9]. 
The concentration f either substrate was 15 rig/ 
1.5 ml incubation mixture. The metabolites pro- 
duced were chromatographed on Sephadex LH-20 
columns. The columns (1 X 65 cm) were equili- 
brated and developed with chloroform : petroleum 
ether 400-60 ° : methanol (75:23:2, v/v/v) [ 10]. 
2.4. Radioactive materials and measurements 
[26, 27-aH]25(OH)D3 (spec. radioact. 9.0 Ci/ 
mmol) was obtained from the Radiochemical 
Centre (Amersham, Bucks). 
[26, 27-aH]3-deoxy-25(OH)D3 was prepared in 
our laboratories from [26, 27-aH]25(OH)D3 as above. 
AU radioactivity measurements were carried out 
in a Packard Tri-Carb automatic liquid-scintillation 
spectrometer no. 3390. Lipid samples were counted 
for radioactivity in a solution of 100 mg 1,4-bis-(5- 
phenyloxazol-2-yl) benzene and 4 mg 2,5-diphenyl- 
oxazole/1, toluene. Quenching was corrected for by 
using the automatic external standardization a d 
correlation curve for all. 
3. Results 
Results hown in table 1 indicate that final body 
weight and % bone ash were significantly (P < 0.05) 
higher in the Da and the high 3-deoxy-25(OH)Dr 
treated chicks than in the other 3 groups which did 
not differ significantly (P > 0.05) from each other. 
Plasma calcium concentration was normal only in the 
D3 and the high 3-deoxy-25(OH)Da4reated bir s. 
Hypocalcemia was observed in all other groups, 
although in the birds which were treated with high 
doses of 3-deoxy-Da the severity of the hypocalcemia 
was reduced. 
Duodenal CaBP was high in the Da-treated chicks, 
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Table 1 
Body weight, plasma calcium, bone ash and duodenal CaBP of chicks treated with the various 
vitamin D derivatives 
January 1979 
Vitamin D Dose Final body Plasma Bone Duodenal 
derivative (#g/day) weight (g) calcium (mg/dl) ash (%) CaBP (mg/g) 
D 3 0.25 222 ± 4 a,f 10.6 ± 0.2 a 37.0 +- 0.7 a 1405 ± 97 a 
3-Deoxy-Da 0.25 174 ± 13 b 6.3 ± 0.1 b 28.3 +- 0.9 b 11 ± 2 b 
3-Deoxy-Da 100 176 ± 9 b 8.4 ± 0.7 c 29.2 ± 0.3 b 133 ± 17 c 
3-Deoxy-25(OH)D 3 0.25 178 ± 15 b 5.9 ± 0.2 b 27.6 ± 0.9 b 45 ± 3 d 
3-Deoxy-25(OH)D 3 100 222 ± 15 a 10.7 ± 0.4 a 3.8.1 ± 0.5 a 924 ± 170 e 
a -e  Means designated by different letters differ significantly (P < 0.01) 
f Mean -+ SEM, obtained from 6 birds 
slightly lower in the high 3-deoxy-25(OH)Da-treated 
chicks, and very low in the rest. The levels measured 
in the low 3-deoxy-Da-treated chicks were close to 
the detection limit. Slightly higher levels were mea- 
sured in the low 3-deoxy-25(OH)D3-treated chicks, 
and still higher levels for high 3-deoxy-D3-treated 
chicks. Since the most important functional group 
of 1,25(OH)2D3 is the hydroxyl at C-l, the observed 
biological effectiveness of 3-deoxy-25(OH)D3, which 
was found to be lower than that of D3, suggested that 
1-hydroxylation f 3-deoxy-D3 might be impaired. In 
order to test this possibility, kidney homogenates 
obtained from vitamin D-deficient chicks were 
incubated with either [26, 27-3H]25(OH)D3 or 
[26, 27-aH]3-deoxy-25(OH)D3. Results given in fig. 1 
show that the conversion of [26, 27-aH]3-deoxy - 
25(OH)D3 into its corresponding 1-hydroxylated 
derivative was impaired. The efficiency of the con- 
versions of [26, 27-3H]3-deoxy-25(OH)D3 and of 
[26, 27-3H]25(OH)D3 to their 1-hydroxylated deriv- 
atives were estimated at 3.8% and 14.3%, respectively. 
4. Discussion 
This report details the chemical synthesis of 
3-deoxy-Da nd 3-deoxy-25(OH)D3, which lack the 
3/3-hydroxyl of the natural vitamin. The synthesis 
was achieved in 2 steps from D3 or from 25(OH)D3, 
respectively. Of the several criteria used here to 
evaluate the biological activity of these analogues 
of vitamin D, intestinal CaBP appeared to be most 
sensitive, in agreement with [ 11,12]. Furthermore, 
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Fig.1. Sephadex LH-20 chromatography of  lipid extracts 
from kidney homogenates which were incubated with 
[26, 27-3H]25(OH)D3 (A) and [26, 27-aH]3-deoxy - 
25(OH)D 3 (B). Curves: (A) peaks 1 and 2 are 25(OH)D 3 
and 1,25(OH)~Da, respectively; (B) peaks 1 and 2 are 
3-deoxy-25(OH)D 3 and 3-deoxy-1,25(OH)~D3, respectively. 
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the present radioimmunoassay with its high sensitiv- 
ity, made possible the distinction between vitamin D 
analogues which possess a low biological activity. 
A 0.25 #g D3/day dose was sufficient o promote 
normal weight gain, bone ash, plasma calcium and 
duodenal CaBP. The two 3-deoxy-analogues given at 
the same doses were found to be inactive, although 
a slight response in terms of duodenal CaBP was 
noted with 3-deoxy-25(OH)Da. With doses as high as 
100 ttg/day, 3-deoxy-25(OH)Da produced a response 
similar to the lower dose of D3. The 3-deoxy-D3, on 
the other hand, produced only marginal responses. 
Thus, 3-deoxy-25(OH)Da is more potent biologically 
than 3-deoxy-D3, and the 3/3-hydroxyl is required for 
the 25-hydroxylation step of D3. 
The low biological activity of 3-deoxy-25(OH)D3 
relative to D3 itself, suggested that the 3~-hydroxyl 
was required for the 1-hydroxylation step in the kid- 
ney. This has been demonstrated also by the poor 
in vitro conversion of this analogue to its 1-hydroxy- 
derivative by kidney homogenates. However, the 
3-deoxy-analogues which had already been hydroxyl- 
ated at C-l, were shown [3] only slightly inferior to 
1,25(OH)2D3. Therefore, the 3/3-hydroxy group is 
more important for the intermediary metabolism of 
the vitamin than for its action on the target organ. 
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